Fig. 7From: Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiencyCaregivers’ survey response on the rate of decline or improvement or improvement in their child’s condition in response to treatment with olipudase alfa (n = 10)Back to article page